These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35504093)

  • 1. Changes in the unregulated opioid drug supply during income assistance payment weeks in Vancouver, Canada: An exploratory analysis.
    Beaulac M; Richardson L; Tobias S; Lysyshyn M; Grant C; Ti L
    Int J Drug Policy; 2022 Jul; 105():103707. PubMed ID: 35504093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada.
    Kennedy MC; Dong H; Tobias S; Buxton JA; Lysyshyn M; Tupper KW; Ti L
    Am J Prev Med; 2024 Jan; 66(1):10-17. PubMed ID: 37633426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 6. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Series Analysis of Fentanyl Concentration in the Unregulated Opioid Drug Supply in a Canadian Setting.
    Tobias S; Grant CJ; Laing R; Arredondo J; Lysyshyn M; Buxton J; Tupper KW; Wood E; Ti L
    Am J Epidemiol; 2022 Jan; 191(2):241-247. PubMed ID: 33977304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
    Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in the unregulated opioid market in the context of extreme rates of overdose.
    Larnder A; Saatchi A; Borden SA; Moa B; Gill CG; Wallace B; Hore D
    Drug Alcohol Depend; 2022 Jun; 235():109427. PubMed ID: 35405459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial.
    Richardson L; Laing A; Choi J; Nosova E; Milloy MJ; Marshall BD; Singer J; Wood E; Kerr T
    Lancet Public Health; 2021 May; 6(5):e324-e334. PubMed ID: 33857455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
    Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018.
    Ickowicz S; Kerr T; Grant C; Milloy MJ; Wood E; Hayashi K
    Subst Abus; 2022; 43(1):458-464. PubMed ID: 34283705
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study.
    Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K
    Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies.
    Bhuiyan I; Tobias S; Ti L
    Am J Drug Alcohol Abuse; 2023 Nov; 49(6):685-690. PubMed ID: 37506334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.